Biomet Total TMJ Study Bias, Adverse Event Rates Acceptable – Panel
This article was originally published in The Gray Sheet
Executive Summary
The concentration of Total TMJ temporomandibular joint replacement procedures at two centers in Biomet's pivotal trial contributed to favorable statistical analysis of the device
You may also be interested in...
Biomet Vanguard Minimally Invasive Knee System To Launch By November
Biomet believes its Vanguard series instrumented, minimally invasive unicondylar knee system will help grow the company's 40% U.S. market share in unicompartmental knees
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.